These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6025265)

  • 1. Failure of synalbumin to exhibit insulin antagonism in vivo.
    Davidson MB; Goodner CJ
    Diabetes; 1967 Jun; 16(6):386-94. PubMed ID: 6025265
    [No Abstract]   [Full Text] [Related]  

  • 2. Conservation of the synalbumin insulin antagonist.
    Vallance-Owen J; McMaster D
    Clin Chim Acta; 1973 Apr; 45(1):99-100. PubMed ID: 4712867
    [No Abstract]   [Full Text] [Related]  

  • 3. Variations in synalbumin insulin antagonism during glucose-tolerance tests.
    Jervell J; Vallance-Owen J
    Lancet; 1967 Jun; 1(7502):1253-4. PubMed ID: 4165040
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of synalbumin insulin antagonist in pathogenesis of diabetes mellitus.
    Davidson MB; Poffenbarger PL
    Metabolism; 1970 Sep; 19(9):668-86. PubMed ID: 4918251
    [No Abstract]   [Full Text] [Related]  

  • 5. In vivo effects of the synalbumin insulin antagonist.
    Kammerer L; Vallance-Owen J
    Diabetologia; 1968 Dec; 4(6):336-8. PubMed ID: 5738374
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the nature of the synalbumin insulin antagonist.
    Holcomb GN; Dulin WE
    Proc Soc Exp Biol Med; 1968 May; 128(1):154-7. PubMed ID: 5656683
    [No Abstract]   [Full Text] [Related]  

  • 7. [Synalbumin insulin antagonism in northern India].
    Bajaj JS; Bansal DD; Gupta SK
    Acta Diabetol Lat; 1971; 8(2):288-94. PubMed ID: 5568106
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative evaluation of the methods for the study of synalbumin insulin antagonism.
    Bajaj JS; Bansal DD; Jindal HO; Garg SK
    Acta Diabetol Lat; 1974; 11(1):26-31. PubMed ID: 4440403
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial purification of an insulin inhibitor from human albumin fractions.
    Alp H; Chaplin H; Recant L
    J Clin Endocrinol Metab; 1966 Mar; 26(3):340-51. PubMed ID: 5908292
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the mechanism of pentobarbital-induced glucose intolerance.
    Davidson MB
    Horm Metab Res; 1971 Jul; 3(4):243-7. PubMed ID: 5129983
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of glucose transport in the postreceptor defect of non-insulin-dependent diabetes mellitus.
    Ciaraldi TP; Kolterman OG; Scarlett JA; Kao M; Olefsky JM
    Diabetes; 1982 Nov; 31(11):1016-22. PubMed ID: 6757010
    [No Abstract]   [Full Text] [Related]  

  • 12. Synalbumin insulin antagonism and protein synthesis.
    Bajaj JS; Bansal DD; Jindal HO
    Acta Diabetol Lat; 1974; 11(6):428-31. PubMed ID: 4478937
    [No Abstract]   [Full Text] [Related]  

  • 13. Glycemia and exercise training alter glucose transport and GLUT4 in the Zucker rat.
    Sherman WM; Friedman JE; Gao JP; Reed MJ; Elton CW; Dohm GL
    Med Sci Sports Exerc; 1993 Mar; 25(3):341-8. PubMed ID: 8455449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phenformin on glucose-insulin interrelationships.
    Stout RW; Brunzell JD; Bierman EL; Porte D
    Diabetes; 1974 Jul; 23(7):624-30. PubMed ID: 4841569
    [No Abstract]   [Full Text] [Related]  

  • 15. [Insulin secretion and insulin sensitivity in subjects with impaired fasting glucose].
    Nishi Y; Yamada Y; Fukushima M; Seino Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():151-4. PubMed ID: 15779360
    [No Abstract]   [Full Text] [Related]  

  • 16. [Insulin secretion after glucose loading. Studies on insulin secretion in healthy and diabetic subjects after administration of glucose].
    Haslbeck M
    Fortschr Med; 1974 Nov; 92(32):1317-8. PubMed ID: 4457437
    [No Abstract]   [Full Text] [Related]  

  • 17. Decreased acylcarnitine content improves insulin sensitivity in experimental mice models of insulin resistance.
    Liepinsh E; Makrecka-Kuka M; Makarova E; Volska K; Svalbe B; Sevostjanovs E; Grinberga S; Kuka J; Dambrova M
    Pharmacol Res; 2016 Nov; 113(Pt B):788-795. PubMed ID: 26621248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and metabolic features of subjects with glucose intolerance and high fasting glucose levels].
    Arteaga Llona A; Pollak F; Robres L; Velasco N
    Rev Med Chil; 2009 Feb; 137(2):193-9. PubMed ID: 19543640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo.
    Huang LC; Fonteles MC; Houston DB; Zhang C; Larner J
    Endocrinology; 1993 Feb; 132(2):652-7. PubMed ID: 8425485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.